Recombinant Human Interleukin-
8, 72a.a./CXCL8-Recombinant Human Interleukin-8, 72a.a./CXCL8- ￥33
- APExBIO
- 美国
- APE-P1123-005
- 2025年07月08日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
该Recombinant Human Interleukin-8, 72a.a./CXCL8产品的保存方式具体查看产品。
- 保质期：
1年
- 英文名：
Recombinant Human Interleukin-8, 72a.a./CXCL8
- 库存：
100
- 供应商：
艾美捷科技
- CAS号：
无
- 规格：
5ug
Recombinant Human Interleukin-8, 72a.a./CXCL8，Recombinant Human Interleukin-8, 72a.a./CXCL8，Recombinant Human Interleukin-8, 72a.a./CXCL8,Recombinant Human Interleukin-8, 72a.a./CXCL8
Recombinant Human Interleukin-8, 72a.a./CXCL8-Recombinant Human Interleukin-8, 72a.a./CXCL8
产品货号：APE-P1123-005
产品规格：5ug
重组人白细胞介素8
Peptides & Proteins|Recombinant Proteins
Recombinant Human Interleukin-8, 72a.a./CXCL8-Recombinant Human Interleukin-8, 72a.a./CXCL8该Recombinant Human Interleukin-8, 72a.a./CXCL8产品的保存方式具体查看产品。
点击：Recombinant Human Interleukin-8, 72a.a./CXCL8-Recombinant Human Interleukin-8, 72a.a./CXCL8查看更详细产品说明，更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多APExBIO公司特色小分子抑制剂等产品评论，请点击查看艾美捷特色产品中心。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Lectin Glycoprofiling of Recombinant Therapeutic Interleukin-7
glycoproteins and particularly relevant for a first study of lot-to-lot comparison, or detection of unwanted glycans. In this chapter, we describe a lectin array-type method specifically designed for the study of recombinant therapeutic interleukin-7 (rhIL
Cytotoxins Directed at Interleukin-4 Receptors as Therapy for Human Brain Tumors
Interleukin-4 (IL-4) is a pleiotropic immune regulatory cytokine that has been extensively studied in the last decade. Activated T-lymphocytes, mast cells, and basophils (1 –3 ) produce it. Consistent with the pleiotropic nature
Hematopoiesis is the process of blood cell formation in the adult human, the bone marrow (BM) is the primary hematopoietic organ. Each day, the BM produces billions of leukocytes, erythrocytes, and thrombocytes, which enter the circulation
技术资料暂无技术资料 索取技术资料
